Liu, Y.; Dai, X.; Jiang, S.; Qahar, M.; Feng, C.; Guo, D.; Wang, L.; Ma, S.; Huang, L.
Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy. Int. J. Mol. Sci. 2022, 23, 8025.
https://doi.org/10.3390/ijms23148025
AMA Style
Liu Y, Dai X, Jiang S, Qahar M, Feng C, Guo D, Wang L, Ma S, Huang L.
Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy. International Journal of Molecular Sciences. 2022; 23(14):8025.
https://doi.org/10.3390/ijms23148025
Chicago/Turabian Style
Liu, Yuhong, Xiaoyong Dai, Shengwei Jiang, Mulan Qahar, Chunyan Feng, Dongdong Guo, Lijun Wang, Shaohua Ma, and Laiqiang Huang.
2022. "Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy" International Journal of Molecular Sciences 23, no. 14: 8025.
https://doi.org/10.3390/ijms23148025
APA Style
Liu, Y., Dai, X., Jiang, S., Qahar, M., Feng, C., Guo, D., Wang, L., Ma, S., & Huang, L.
(2022). Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy. International Journal of Molecular Sciences, 23(14), 8025.
https://doi.org/10.3390/ijms23148025